Home › Research › Risk factors
The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies
Galbiati A, Verga L, Giora E, Zucconi M, Ferini-Strambi L.. Sleep medicine reviews, 2018-11-08
Topic: Risk, prevention and care in population studies
Plain-language summary
Several studies report an association between REM Sleep Behavior Disorder (RBD) and neurodegenerative diseases, in particular synucleinopathies. Interestingly, the onset of RBD precedes the development of neurodegeneration by several years. This review and meta-analysis aims to establish the rate of conversion of RBD into neurodegenerative diseases. Longitudinal studies were searched from the PubMed, Web of Science, and SCOPUS databases. Using random-effect modeling, we performed a meta-analysis on the rate of RBD conversions into neurodegeneration. Furthermore, we fitted a Kaplan-Meier analysis and compared the differences between survival curves of different diseases with log-rank tests. The risk for developing neurodegenerative diseases was 33.5% at five years follow-up, 82.4% at 10.5 years and 96.6% at 14 years. The average conversion rate was 31.95% after a mean duration of follow-up of 4.75 ± 2.43 years. The majority of RBD patients converted to Parkinson's Disease (43%), followed by Dementia with Lewy Bodies (25%). The estimated risk for RBD patients to develop a neurodegenerative disease over a long-term follow-up is more than 90%. Future studies should include control group for the evaluation of REM sleep without atonia as marker for neurodegeneration also in non-clinical population and target RBD as precursor of neurodegeneration to develop protective trials.
What this study adds
Evidence grade: High
This is a pooled review. This meta-analysis of longitudinal studies found that people with REM sleep behavior disorder had a high estimated risk of developing a neurodegenerative disease over long-term follow-up, with most converting to Parkinson's disease and then dementia with Lewy bodies. Reported effect size: 33.5%; 82.4%; 96.6%.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Galbiati, A., Verga, L., Giora, E., Zucconi, M., & Ferini-Strambi, L. (2019). The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies. Sleep medicine reviews. https://doi.org/10.1016/j.smrv.2018.09.008
Vancouver
Galbiati A, Verga L, Giora E, Zucconi M, Ferini-Strambi L. The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies. Sleep medicine reviews. 2019. doi:10.1016/j.smrv.2018.09.008. PMID: 30503716.
BibTeX
@article{galbiati2019-30503716,
author = {Galbiati, A. and Verga, L. and Giora, E. and Zucconi, M. and Ferini-Strambi, L.},
title = {{The risk of neurodegeneration in REM sleep behavior disorder: A systematic review and meta-analysis of longitudinal studies}},
journal = {Sleep medicine reviews},
year = {2019},
doi = {10.1016/j.smrv.2018.09.008},
pmid = {30503716},
url = {https://doi.org/10.1016/j.smrv.2018.09.008}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. Check the citation against the original before you use it.
Key findings
- The risk for developing neurodegenerative diseases was 33.5% at five years follow-up, 82.4% at 10.5 years and 96.6% at 14 years.
- The average conversion rate was 31.95% after a mean duration of follow-up of 4.75 ± 2.43 years.
- The majority of RBD patients converted to Parkinson's Disease (43%), followed by Dementia with Lewy Bodies (25%).
- The estimated risk for RBD patients to develop a neurodegenerative disease over a long-term follow-up is more than 90%.
- Future studies should include control group for the evaluation of REM sleep without atonia as marker for neurodegeneration also in non-clinical population and target RBD as precursor of neurodegeneration to develop protective trials.
Why it matters
This meta-analysis of longitudinal studies found that people with REM sleep behavior disorder had a high estimated risk of developing a neurodegenerative disease over long-term follow-up, with most converting to Parkinson's disease and then dementia with Lewy bodies. It suggests that future studies should target REM sleep behavior disorder as a precursor of neurodegeneration to develop protective trials.
New to this subject? Start with our plain-English guide: Risk factors, ranked →
Study details
- Study designmeta-analysis
- Effect size33.5%; 82.4%; 96.6%
- Evidence strengthHigh
How this study scored 66/100
Published in a peer-reviewed journal, and it is a meta-analysis pooling many studies. Scored zero for sample size and studied in people because the record does not state it.
| Component | Points | Why |
|---|---|---|
| Journal tier | 7 / 10 | Tier 3 — peer-reviewed journal (Sleep medicine reviews) |
| Journal's citation record | 2 / 4 | Sleep Medicine Reviews: journal h-index 227 (OpenAlex, 2026-10-29) |
| Study design | 12 / 12 | A meta-analysis pooling many studies |
| Strength of evidence | 5 / 5 | Rated “high” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 2 / 5 | 2019 — within 10 year(s) of the newest study here |
| Sample size | 0 / 4 | Participant count not stated — scores zero (not stated in the record — scored 0) |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 0 / 3 | Not stated whether this was studied in people — scores zero (not stated in the record — scored 0) |
| Randomized / blinded | 0 / 2 | A review of other studies — randomization is not credited here |
| Times cited | 6 / 7 | Cited 369 times (OpenAlex, 2026-10-10) |
| Citations per year | 4 / 5 | 41.0 citations a year over 9 year(s) since 2019 |
| Impact for its field and year | 3 / 6 | Cited 4.8× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 2 / 6 | Cited by 4 other studies in this library |
| Still being cited | 3 / 4 | Cited 176 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 3 / 4 | Last-listed author Luigi Ferini‐Strambi: h-index 90 (OpenAlex, whole career) |
| Institution's track record | 1 / 3 | Maastricht University: institution h-index 876 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 4 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 30503716) |
| Free to read | 0 / 2 | Behind a paywall — scores zero |
| Total | 66 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
May need a subscription OpenAlex found no free copy of the full text (checked 6 Feb 1020), so the publisher may charge for it. The PubMed abstract is free.
Related
Studies in the library that share something with this one. The line above each title says what.
Studies this one cites
Referenced by this study and also in the alzhub library, so you can read them here.
Later studies that cite this one
4 studies in the alzhub library list this one in their references.
Related studies in Risk factors from nearby years
Also tagged “biobank”
1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.